Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: $Mogul who wrote (61637)	1/12/2000 6:26:00 PM
From: Mr. Big	Respond to of 108040

Taking a mini-me stab at VISG. ISIP or VISG could be the next lottery ticket.

To: $Mogul who wrote (61637)	1/12/2000 6:26:00 PM
From: ezmoney	Respond to of 108040

How did you like ACCR today & we met the 52 week high imo. this is the begining do some DD & you will see !

To: $Mogul who wrote (61637)	1/12/2000 6:37:00 PM
From: StoxRider	Read Replies (2) \| Respond to of 108040

Princeton, New Jersey, Jan. 7 (Bloomberg Data) -- Isis Pharmaceuticals Inc. (ISIP US) was reiterated short-term ``outperform' by analyst Jeffrey J. Kraws at Gruntal & Co. The long-term rating was also reiterated 'outperform.' The short-term and long-term price targets are $43 and $52 per share, respectively.